On February 24, 2026, Brainstorm Cell Therapeutics Inc. agreed to sell shares and warrants worth $1,000,000 to an investor, starting with a $125,000 closing amount, with proceeds intended for working capital. Additionally, on February 26, 2026, the company increased its stock incentive plan by 5,500,000 shares.